NCT04304599 - Evaluation of a New Female Urinary Intermittent Catheter | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

January 3, 2023

Study Completion Date

February 27, 2023

Conditions

Female Intermittent Urethral Catheterization

Interventions

DEVICE

LoFric Elle

The study device is commercially available (CE-marked). It is a device for female intermittent catheterization. Treatment Period will last for 2 weeks. The angulated handle available with the device must be used by each subject at least 10 times.

Trial Locations (4)

Unknown

Alicante University General Dr. Balmis Hospital, Alicante

Hospital Clinic Barcelona, Barcelona

SE-405 45

Carlanderska Hospital, Gothenburg

701 85

Urologiska kliniken, mottagning Universitetssjukhuset Örebro, Örebro

All Listed Sponsors

lead

Wellspect HealthCare

INDUSTRY